Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

After Spate of Transformative Acquisitions, Endo Reports Robust Growth for 1H 2011

This article was originally published in The Pink Sheet Daily

Executive Summary

Endo's blended business model appears to be paying off in the near term as the company raises guidance for 2011, driven by the acquisition of American Medical Systems in June and strength in its core franchises.
Advertisement

Related Content

Medical Device and In Vitro Diagnostics/Research Deals Statistics Quarterly, Q2 2011
Medical Device and In Vitro Diagnostics/Research Deals Statistics Quarterly, Q2 2011
Endo Dives Deeper Into Devices With AMS Acquisition
Endo Dives Deeper Into Devices With AMS Acquisition
Endo Launches Fortesta, Raises 2011 Guidance
Endo Diversifies Further With Purchase Of Qualitest for $1.2 Billion

Topics

Advertisement
UsernamePublicRestriction

Register

PS072742

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel